EMITF 8:28am 14.60 +1.42 +10.77%
Nothing will slow down for this company,not as long as Zisser is around.
Read my lips.....
I am 80 next month.....
Although KOSHER is not the equivalent word for
TASTY....you might be surprised to know how many non Jews prefer eating Kosher food.
The Moslems for one,not a marginal market,is a big consumer ,although not because of love to Israeli or Jewish products,but because of similar religious beliefs concerning foods......
Moreover,let me post an opinion published in the Globes:
Willi-Food is a completely different story. I don't know what happened yesterday, other the report that the mighty Louis Navellier holds some Willi-Food shares in one of his funds. As I've said before, though, with all due respect to Wall Street, Procter and Gamble, and the giant supermarket chains, Willi-Food has something they haven't got a specialty in kosher food. They are able to bring
to the US 400 or 1,000 different kinds of kosher food products, at competitive prices.
I know something about this field, and I've already told you before the share shot up 200% that this is one of the most interesting shares on Wall Street, because it's got everything. It's got a story that every American kid can understand, and grownups, too, of course. It's got potential for a huge profit, and it's got the old
(and new) way of thinking: "Who will let them get big? One of the distribution chains will buy them out, long before they manage to get big."
I believe that each one of the neglected shares that I mentioned has the potential for an upward surge, but that's my opinion, and it's best for everyone to do his own due diligence. The fact that there's no analyst coverage can only help.
Published by Globes [online] - www.globes.co.il - on March 1, 2005
BTW;I tried some of their products,Lo & behold I found it tasty on top of its being kosher(a benefit by itself)
+If you can't say something nice, say it in Yiddish.
+A bad matzoh ball makes a good paperweight.
As for other foods;
+According to Jewish dietary law, pork and shell fish may be eaten only in Chinese restaurants.
This was a stupid response, medicine and food has the most profit margin, ahhh and sex :-)
The Italian says, "I'm tired and thirsty. I must have wine."
The Frenchman says, "I'm tired and thirsty. I must have cognac."
The Russian says, "I'm tired and thirsty. I must have vodka."
The German says, "I'm tired and thirsty. I must have beer."
The Mexican says, "I'm tired and thirsty. I must have tequila."
The Jew says, "I'm tired and thirsty. I must have diabetes."
BTW,SCIX is on top of my EMITF,not instead of.
My buy sentiment disclosure is still valid
As for SCIX,I have candidly stated i placed my money where my hopes are.
HOPES not FACTS.
BTW...2 I also think WILCF is a wise choice
no science,no spinoffs,just a good old fashioned growing FOOD company.
(O how boring)
There have been rumours about a huge 3 $ dividend;
Scitex (Nasdaq: SCIX; TASE: SCIX) rose 3.3% today, after a press report this morning that the company was expected to shortly distribute a $120 million dividend ($3 per share). If the report is correct, it amounts to over half of Scitex's market cap as of this morning. The company has not yet commented about the report, but the share responded strongly.
Published by Globes [online], Israel business news - www.globes.co.il - on February 22, 2005
If,and i repeat, if indeed this rumour is true,it WILL have a HUGE positive impact.
The rumour was there in PRINT,and with todays earnings at 1700 EST SCIX is to provide financial info ,quarterly and annual report.
Not long to wait in order to find out if this rumour WAS just a rumour or is finally ratified (or NOT).
A general piece of advice is NEVER to put all your eggs in the same basket,after all if i was 100% sure of any STOCK i would put ALL my money in it,wouldn't i?
Do your own DD and never EVER follow my advice,for i have been WRONG more often than not.
If EMITF as good as you claim why do you like SCIX? Do they have any similar story? Dividend? spin off?
EMITF went up a bit high and that is scary although the spin-off will bring it allot of added value.
1/Interest about InSightec was really phenomenal." InSightec, a subsidiary of GE Healthcare and Elbit Medical Imaging (Nasdaq:EMITF; TASE:EMIT) in unequal shares, has technology that is supposed to be the latest word in treating uterine fibroids.
2/ Zisser plans $1b Insightec flotation
By Omri Cohen
Moti Zisser is planning one of the greatest Israeli offerings of the year. His company Elbit Medical Imaging is planning to float Insightec Imaging Guided Therapy at a company value of $1 billion, Haaretz learned yesterday.
The IPO tentatively is to take place by the end of Q3, Zisser said told institutional investors in Tel Aviv yesterday.
Elbit Medical owns 52 percent of Insightec. The parent company, which began as a medical-technology firm but which Zisser bought and converted into a real estate investment vehicle, is worth NIS 1 billion. If he gets the price he wants for Insightec, Elbit Medical's value would soar.
The putative offering targets Nasdaq, naturally: negotiations with potential underwriters have apparently commenced.
News of Zisser's ambitious plans sent Elbit Medical stock soaring 15.73 percent on the Tel Aviv Stock Exchange yesterday.
Insightec investors include GE Capital, the global investment fund run by General Electric.
Insightec has developed noninvasive technology to treat tumors. The company's ExAblate has received US Food and Drug Administration approval to treat uterine fibroids, which are clumps of tissue that can cause miscarriages, painful menstruation and related problems in women.
The system uses ultrasound waves to break up the clumps, and can provide an alternative to the removal of a uterus, or hysterectomy. But the FDA noted that ExAblate is not intended for women who want to get pregnant in the future.
Each machine costs about $1 million. Insightec has sold 10 of them so far, to hospitals. Any healthcare outfit buying the device will return its investment in 230 treatments, inventors told the investors yesterday.
3/Elbit Medical Imaging Responds to Website Article Regarding InSightec
Tuesday February 8, 12:04 pm ET
TEL-AVIV, Israel, Feb. 8 /PRNewswire-FirstCall/ -- Elbit Medical Imaging Ltd. (Nasdaq: EMITF - News; "EMI") shared the following response to an article published today on Israel's The Marker website, concerning a public offering (IPO) of InSightec Image Guided Treatment Ltd. ("InSightec").
EMI hereby clarifies that EMI is indeed considering a possible initial public offering of InSightec. However, the precise date of the IPO as well as value of InSightec for purposes thereof, have not yet been determined.
The information published in the said article with respect to the expected value of InSightec under the IPO was not provided by EMI.